Houle Gabrielle, Ambalavanan Amirthagowri, Schmouth Jean-François, Leblond Claire S, Spiegelman Dan, Laurent Sandra B, Bourassa Cynthia V, Grayson Celene, Panisset Michel, Chouinard Sylvain, Dupré Nicolas, Vilariño-Güell Carles, Rajput Alex, Girard Simon L, Dion Patrick A, Rouleau Guy A
Montreal Neurological Institute and Hospital (G.H., A.A., J.-F.S., C.S.L., D.S., S.B.L., C.V.B., P.A.D., G.A.R.), Quebec, Canada; Department of Human Genetics (G.H., A.A., C.S.L., P.A.D., G.A.R.) and Department of Neurology and Neurosurgery (J.-F.S., P.A.D., G.A.R.), McGill University, Montreal, Quebec, Canada; Xenon Pharmaceuticals Inc (C.G.), Burnaby, British Columbia, Canada; André Barbeau Movement Disorders Unit (M.P., S.C.), Centre Hospitalier Universitaire de Montréal (CHUM)-Notre-Dame, Quebec, Canada; Department of Medicine (N.D.), Faculty of Medicine, Laval University, Quebec, Canada; Département des Sciences Neurologiques (N.D.), CHU de Québec (Enfant-Jésus), Quebec, Canada; Department of Medical Genetics (C.V.-G.), University of British Columbia, Vancouver, British Columbia, Canada; Division of Neurology (A.R.), Saskatchewan Movement Disorders Program, University of Saskatchewan, Saskatoon Health Region, Saskatoon, Canada; and Département des Sciences Fondamentales (S.L.G.), Université du Québec à Chicoutimi, Saguenay, Canada.
Neurol Genet. 2017 Oct 19;3(5):e195. doi: 10.1212/NXG.0000000000000195. eCollection 2017 Oct.
To assess the contribution of variants in , , and as essential tremor (ET) predisposing factors following their association in a 2-stage genome-wide association study (GWAS).
The coding regions of these genes was examined for the presence of rare variants using two approaches: (1) Looking at whole-exome and whole-genome sequencing data of 14 autosomal dominant multiplex ET families. (2) Conducting a targeted massive parallel sequencing to examine the three genes in cohorts of 269 ET cases and 287 control individuals. The cumulative impact of rare variants was assessed using SKAT-O analyses using (1) all variants, (2) only rare variants, and (3) only the rare variants altering the mRNA.
Thirty-four variants were identified. No difference emerged regarding the distributions of individual variants (or gene) between cases and controls.
No rare exonic variants further validated one of these genes as a risk factor for ET. The recent GWAS offers promising avenues, but the genetic heterogeneity of ET is nonetheless challenging for the validation of risk factors, and ultimately larger cohorts of cases should help to overcome this task.
在一项两阶段全基因组关联研究(GWAS)中,评估 、 和 基因的变异作为特发性震颤(ET)易感因素的作用。
采用两种方法检测这些基因编码区罕见变异的存在情况:(1)查看14个常染色体显性遗传的多病例ET家系的全外显子组和全基因组测序数据。(2)进行靶向大规模平行测序,检测269例ET病例和287例对照个体队列中的这三个基因。使用SKAT - O分析评估罕见变异的累积影响,分析时采用(1)所有变异,(2)仅罕见变异,以及(3)仅改变mRNA的罕见变异。
共鉴定出34个变异。病例组和对照组之间在单个变异(或基因)的分布上未出现差异。
没有罕见的外显子变异进一步证实这些基因中的任何一个是ET的危险因素。近期的GWAS提供了有前景的途径,但ET的遗传异质性对危险因素的验证仍是一个挑战,最终更大规模的病例队列应有助于完成这项任务。